Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies

  • Diane Nguyen1,
  • Enrique Seoane-Vazquez1,
  • Rosa Rodriguez-Monguio2Email author and
  • Michael Montagne1
BMC Health Services Research201313:27

DOI: 10.1186/1472-6963-13-27

Received: 30 July 2012

Accepted: 16 January 2013

Published: 22 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
30 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Jul 2012 Author responded Author comments - Rosa Rodriguez-Monguio
Resubmission - Version 3
30 Jul 2012 Submitted Manuscript version 3
30 Aug 2012 Reviewed Reviewer Report - Elaine Morrato
15 Oct 2012 Reviewed Reviewer Report - Sujit Sansgiry
18 Nov 2012 Author responded Author comments - Rosa Rodriguez-Monguio
Resubmission - Version 4
18 Nov 2012 Submitted Manuscript version 4
28 Nov 2012 Author responded Author comments - Rosa Rodriguez-Monguio
Resubmission - Version 5
28 Nov 2012 Submitted Manuscript version 5
Publishing
16 Jan 2013 Editorially accepted
22 Jan 2013 Article published 10.1186/1472-6963-13-27

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
International Center of Pharmaceutical Economics and Policy, Massachusetts College of Pharmacy & Health Sciences
(2)
University of Massachusetts

Advertisement